Piedmont and Aosta Valley inter-regional network in the context of the Italian National Network for rare diseases

Affiliations

¹ CMID - Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of Piedmont and Aosta Valley Network for Rare Diseases, St. G. Bosco Hospital and University of Turin, Turin, Italy Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
² Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
³ CMID - Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of Piedmont and Aosta Valley Network for Rare Diseases, St. G. Bosco Hospital and University of Turin, Turin, Italy.
⁴ Piedmont Regional Health Department, Turin, Italy.

Review

Simone Baldovino et al. Blood Transfus. 2014 Apr.

. 2014 Apr;12 Suppl 3(Suppl 3):s617-20.

doi: 10.2450/2014.0055-14s.

¹ CMID - Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of Piedmont and Aosta Valley Network for Rare Diseases, St. G. Bosco Hospital and University of Turin, Turin, Italy Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
² Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
³ CMID - Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of Piedmont and Aosta Valley Network for Rare Diseases, St. G. Bosco Hospital and University of Turin, Turin, Italy.
⁴ Piedmont Regional Health Department, Turin, Italy.

No abstract available

References

1. Taruscio D, Cerbo M. Rare diseases: general principles, specific problems, and health interventions. Ann Ist Super Sanita. 1999;35:237–44. - PubMed
1. Prevalence of rare diseases: Reference data listed in order of decreasing prevalence or number of published cases. [Accessed on 27/02/2014]. Available at: http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_disease....
1. Murphy SM, Puwanant A, Griggs RC, et al. Unintended effects of orphan product designation for rare neurological diseases. Ann Neurol. 2012;72:481–90. - PMC - PubMed
1. Programme of Community Action on Rare Diseases (1999–2003)Decision No 1295/99/EC of the European Parliament and of the Council of 29 April 1999. O.J. n° L 155 of 22.06.1999. [accessed on 07/04/2014]. p. 1. Available at: http://ec.europa.eu/health/archive/ph_overview/previous_programme/rare_d....
1. Taruscio D, Capozzoli F, Frank C. Rare diseases and orphan drugs. Ann Ist Super Sanita. 2011;47:83–93. - PubMed